All In MedTech

FDA Clearance Tracker · P200031-S007

Organ Care System (OCS™) Liver

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 13, 2025

Approved

Time to decision

179 days

Received Jul 18, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200031-S007
Device name
Organ Care System (OCS™) Liver
Applicant location
Andover, MA
Received
Jul 18, 2024
Decided
Jan 13, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200031

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

Approval for the implementation of an alternative oxygenator, identified as the Maquet Quadrox-i, for the Organ Care System Liver

Source documents

Other decisions for TransMedics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.